Close menu




December 17th, 2025 | 07:05 CET

How Bayer, WashTec, and Volkswagen will earn more money in the future with digitalization and AI

  • Automotive
  • carwash
  • Technology
  • Digitization
  • AI
  • Pharma
  • Electromobility
Photo credits: pixabay.com

Artificial intelligence is already generating measurable profits in industry today. In the pharmaceutical and chemical industries, it is revolutionizing research and accelerating the market launch of vital products. Mechanical and plant engineering is tapping into recurring sources of revenue with AI-based services and strengthening customer loyalty. And in the automotive industry, autonomous driving is highly popular and will shape the future. These advances prove that the productive phase of AI has begun. Three companies show how technology translates into competitive advantages and robust margins: Bayer, WashTec, and Volkswagen.

time to read: 4 minutes | Author: Armin Schulz
ISIN: BAYER AG NA O.N. | DE000BAY0017 , WASHTEC AG O.N. | DE0007507501 , VOLKSWAGEN AG VZO O.N. | DE0007664039

Table of contents:


    Bayer – How AI accelerates the pipeline

    At Bayer, artificial intelligence is increasingly becoming a key technology for drastically reducing development times and bringing innovations to market more quickly. In the pharmaceutical business in particular, the Company relies on powerful platforms such as ALYCE. It sifts through enormous amounts of clinical data to identify promising drug candidates and make clinical trials more efficient. This is a real game-changer for the entire development process. In agriculture, AI is halving the time needed to breed new seed varieties with the help of digital twins and tools such as CropKey. This data-driven approach aims to make the leading research pipeline, with a potential value of over EUR 30 billion, even more valuable and generate long-term growth.

    Operationally, Bayer is currently receiving tailwinds from its pharmaceuticals division. Recently, the experimental anticoagulant asundexian achieved its primary goals in a large Phase 3 study on stroke prevention, a significant milestone. In addition, two other drugs, Lynkuet for menopausal symptoms and Sevabertinib for a specific type of lung cancer, received important approvals in the US and the EU. These successes underscore the Company's innovative strength and diversify its portfolio, while established blockbusters such as Nubeqa and Kerendia continue to grow strongly.

    The financial outlook remains dominated by the need to deal with legacy issues. Although recent signals from the US point to a possible legal easing of the glyphosate issue, clarity is not expected until 2026. Against this backdrop, debt reduction is a clear priority. The dividend has therefore been reduced to a symbolic minimum of EUR 0.11 per share and is expected to remain at this level until the balance sheet has been significantly strengthened. For investors, the turnaround story is currently the focus, not the dividend. The share is currently trading at EUR 35.905.

    WashTec – More than just steel and water

    WashTec is undergoing a remarkable transformation. The Company is deliberately evolving from a pure manufacturer of car wash systems to a provider of digital services. Instead of just selling machines, it is now focusing on software solutions that help operators increase their revenue and optimize their processes. Platforms such as EasyCarWash PRO enable flexible pricing models and better customer loyalty. This step opens the door to recurring revenue and makes the business less cyclical. Initiatives such as "WashNow" are even testing direct integration into vehicle systems. This digital networking creates completely new sales channels and strengthens customer relationships in the long term.

    This strategy is already translating into improved financial performance. In the first nine months of 2025, revenue increased by more than 7%, while operating profit grew more strongly. The EBIT margin expanded to 11.8%, driven primarily by strong performance in European business. The resulting cash generation provides strategic flexibility and supports shareholder returns. A significant increase in the order backlog also points to sustained demand. Against this backdrop, the margin targets of 12-14% appear realistic.

    Capital return policy is important for investors. WashTec pays a regular dividend, most recently EUR 2.40 per share. In addition, a share buyback program is in place. For example, in the week before December 8, shares were repurchased on the stock exchange every day, totaling over 7,000 shares during this period. This combined strategy underscores the financial confidence of the management. The program, with a volume of up to EUR 5 million, will run through May 2026. The Executive Board is thus clearly signaling that it considers its own shares to be undervalued. The share is currently trading at EUR 46.40.

    Volkswagen – AI on German roads

    Volkswagen is increasingly relying on artificial intelligence to reduce costs and optimize processes. The group sees potential savings in the high single-digit billion range by 2035. Another example of this development is currently rolling through Wolfsburg. The autonomous research vehicle Gen.Urban is testing real-world city traffic there without a steering wheel or pedals. These trials are intended to provide important data on how passengers might accept and use self-driving vehicles in the future. The aim is to build trust in the technology and to align future vehicle concepts at an early stage.

    Despite positive sales figures for electric vehicles, pricing remains a challenge. Volkswagen is responding to this with an increase in in-house production of battery systems. The new assembly plant in Spain is a central component of this strategy. From 2027, more cost-effective LFP battery cells are to be manufactured there. This is the technological prerequisite for bringing electric vehicles to market for around EUR 25,000 from next year. The goal is clear: to drive electrification forward in the volume segment as well and remain competitive against cheaper competitors.

    The Group's financial situation is tense, as reflected in the recently decided dividend cut to EUR 6.36 per preferred share. Nevertheless, the current yield of just under 6% continues to signal an attractive income component for shareholders. The outlook is characterized by strict cost discipline and focused investments of EUR 160 billion by 2030. Success will depend largely on whether the planned e-offensive in the low-price segment takes off and the comprehensive efficiency programs, including AI, take effect. For investors, it remains a bet on the successful transformation. The share price is currently trading at EUR 108.05.


    The productive phase of digitalization has been reached and is increasingly becoming a key profit driver. Bayer is accelerating research through AI, thereby increasing the value of its pipeline. WashTec is transforming itself from a machine manufacturer to a provider of recurring, high-margin revenues through digital services. Volkswagen is relying on AI for billions in efficiency gains and is tapping into new future markets with autonomous driving. For all three companies, digital transformation is no longer a promise for the future, but a lever for competitive advantages and more robust finances today.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Armin Schulz

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author



    Related comments:

    Commented by Carsten Mainitz on November 10th, 2026 | 05:45 CET

    Exciting pharma duel: Who will take off now - BioNxt Solutions, Bayer or Novo Nordisk?

    • Pharma
    • Biotech
    • Innovations
    • Diabetes

    New active ingredients, expanded indications and more user-friendly dosage forms are driving momentum in the global pharmaceutical market. BioNxt Solutions is focusing on novel oral dissolvable films and working towards regulatory and clinical breakthroughs. Industry heavyweights Bayer and Novo Nordisk have recently reported solid quarterly results. Bayer has already overcome several challenges and raised its outlook. At the same time, Novo Nordisk is impressively demonstrating how innovative forms of administration in obesity treatment can achieve soaring commercial success. Where do the most attractive opportunities for investors lie following the latest developments?

    Read

    Commented by Stefan Feulner on November 10th, 2026 | 05:35 CET

    BYD, HPQ Silicon and BMW – The battery race escalates

    • Battery technology
    • Electromobility

    Created and published on behalf of HPQ Silicon

    503 km/h in an electric vehicle, a new generation of batteries from Bavaria and silicon technology for more powerful energy storage: the technological race between China and Europe is intensifying. While BYD shows what modern electric powertrains can achieve with a new speed record, BMW is investing billions in industrial production of its next-generation batteries. At the same time, specialist developers are working to push the limits of today's lithium-ion cells. Higher energy density, lower weight and longer operating times are becoming key competitive factors.

    Read

    Commented by Tarik Dede on November 9th, 2026 | 05:27 CET

    Copper under election pressure: Southern Copper, Power Metallic Mines and Freeport McMoran in focus

    • Copper
    • Zinc
    • AI
    • Midterms
    • Southern Copper
    • Freeport-McMoRan
    • Power Metallic Mines

    Created and Published on Behalf of Power Metallic Mines

    Two factors boosted the upward trend in copper over recent months and years. One was the additional demand from the massive expansion of AI infrastructure in the US by the so-called AI hyperscalers. The other was the threat of tariffs hanging over the market. The US government planned such tariffs to promote domestic mining and bring more processing capacity into the country. Both factors have been called into question since last week's midterm elections. The Democrats want to slow the expansion of data centres and regulate AI players such as OpenAI or Anthropic more tightly. Both weighed on the copper price last week, which fell to its lowest level since July. "Markets are still digesting the implications of a blue wave", wrote Daniel Ghali, head of commodities research at Deutsche Bank, summarising the current market situation. This does not jeopardise the structural rise in demand for copper. Nevertheless, progress could be somewhat slower for the time being. For investors, this market situation offers opportunities in battered copper stocks. Today, we take a look at the shares of Southern Copper, Power Metallic Mines and Freeport McMoRan.

    Read